DIG
STLN

Dauntless Investment Group’s Starling Oncology STLN Stock Holding History

Dauntless Investment Group’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$888K Sell
163,570
-298,487
-65% -$1.25M 0.7% 30
2026
Q1 		$1.42M Buy
+462,057
New +$1.42M 0.94% 15

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dauntless Investment Group's STLN Position: Q2 2026 in Review

Dauntless Investment Group reduced its Starling Oncology (STLN) stake by 65% in Q2 2026, selling an estimated $1.25M and leaving 163,570 shares worth $888K. The position accounts for 0.7% of the portfolio, ranked #30.

Dauntless Investment Group first reported a position in STLN in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.42M in Q1 2026. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Dauntless Investment Group held 163,570 shares of Starling Oncology worth $888K as of Q2 2026.
  • Dauntless Investment Group sold 298,487 Starling Oncology shares in Q2 2026, an estimated $1.25M.
  • Starling Oncology made up 0.7% of Dauntless Investment Group's portfolio in Q2 2026, its #30 holding.
  • Dauntless Investment Group first reported a position in Starling Oncology in Q1 2026 and has held it in 2 quarters since.
  • Dauntless Investment Group's Starling Oncology position peaked at $1.42M in Q1 2026.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Dauntless Investment Group's 13F filing for Q2 2026, filed 13 Aug 2026.